KEY PRODUCTS
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
01 2ATHENA
02 4TRIS PHARMA INC
01 68337890
01 6Blank
01 6Y
01 42027-03-15
02 22027-04-17
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Patent Expiration Date : 2027-04-17
US Patent Number : 8337890
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22500
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-17
Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.
Patent Expiration Date : 2027-04-17
US Patent Number : 8337890
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22500
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-04-17
Patent Expiration Date : 2027-03-15
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 8337890
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210526
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-15
Patent Expiration Date : 2027-03-15
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 8337890
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210526
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-15
Patent Expiration Date : 2027-03-15
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 8337890
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210526
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-15
Patent Expiration Date : 2027-03-15
AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
US Patent Number : 8337890
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 210526
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-03-15
